BROOKLINE, Mass., Nov. 25 /PRNewswire/ -- A Food and Drug Administration
General and Plastic Surgery Devices Advisory Panel met Friday to review and
recommend approval of the use of Hyaluronic Acid, under the name
Restylane(TM), for non surgical use through injections for patients wishing to
smooth wrinkles, sculpt lips and shape facial contours. "Hyaluronic Acid has
been used safely and effectively for over 25 years in eye surgery to assist in
the removal of cataracts," said Stephen Sohn, M.D., a Diplomate of the
American Board of Plastic Surgery and Founder of the Institute for Medical
Aesthetics.
    Restylane(TM) is a crystal-clear, non-animal, biodegradable gel based on a
natural substance, called Hyaluronic acid. The gel is injected into the skin
in tiny amounts with a very fine needle. The result is instantaneous and
produces a long-lasting, natural enhancement, gentle and safe to your skin.
    Commented Dr. Sohn, "We have been using dermal fillers such as collagen
for over 20 years with excellent safety and cosmetic results for our
patients -- we are optimistic based on my international colleague's reports,
that Restylane(TM) will provide us with an additional non-surgical treatment
approach for enhancing facial contours and smoothing wrinkles."
    Q-Med AB of Uppsala, Sweden, the manufacturer of Restylane(TM), reports
that since 1996, more than a million people have been successfully treated in
more than 60 countries worldwide.  "As with any medical aesthetic procedure,
careful consultation and patient selection, as well as the experience and
skill of the treating physician will be critical in order to achieve the best
results," said Dr. Sohn.

    The Institute for Medical Aesthetics Mission
    The Institute's Mission is to help people, primarily women, with life-long
aesthetic management. The thrust of our efforts is to achieve an understanding
of the aging process and in that context, provide ways to best maintain and
enhance personal beauty.

Link to this page: